Nanowerk February 28, 2018
Researchers in Russia used magnet-driven nanoparticles consisting of two key components – thrombin, an enzyme responsible for blood clotting and magnetite. Thrombin interacts with the protein called fibrinogen and triggers clot formation to block the damaged vessel. The thrombin is wrapped into a special porous matrix made of magnetite that allows for precise control of the movement of particles inside the body using an external magnetic field. A drug based on these nanoparticles is nontoxic and can be injected intravenously and delivered straight to the site of a vascular injury. It can accelerate local clot formation and reduce overall blood loss by up to 15 times… read more. Open Access TECHNICAL ARTICLE
Magnetic nanoparticles will help stop internal bleeding 15 times more effectively
Posted in Biotechnology, Nanotechnology and tagged medical nanotechnology, Medical science, S&T Russia.